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Abstract
BACKGROUND
Inflammatory myofibroblastic tumors of the liver (IMTL) are extremely rare
neoplasms and very little is known about their clinical presentation,
pathogenesis, and biological behavior. Due to their absolute rarity, it is almost
impossible to obtain a definite diagnosis without histological examination.
Because of their intermediate biological behavior with the risk for local
recurrence and metastases, surgical resection is recommend whenever IMTL is
suspect.
CASE SUMMARY
We herein present a case of an otherwise healthy 32-year-old woman who
presented with intermittent fever, unclear anemia, malaise and right flank pain 4
mo postpartum. The liver mass in segment IVa/b was highly FDG avid in the
positron emission tomography-computed tomography. Hepatic resection was
performed achieving a negative resection margin and an immediate resolution of
all clinical symptoms. Histological analysis diagnosed the rare finding of an
inflammatory myofibroblastic tumor of the liver and revealed cytoplasmic
anaplastic lymphoma kinase expression by immunohistochemistry. Twelve
months follow-up magnetic resonance imaging showed no recurrence and no
metastases in the fully recovered patient.
CONCLUSION
IMTLs are extremely rare and difficult to diagnose. Due to their intermediate
biological behavior, surgical resection should be perform whenever feasible and
patients should be followed-up in order to detect recurrence and metastasis as
early as possible.
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Core tip: In summary of the literature and with the experience from our own recent case,
complete surgical resection of suspected inflammatory myofibroblastic tumors of the
liver should be the preferred treatment of choice in order to rule out malignancy, avoid
long-term medical treatment and to be able to recommend an appropriate follow-up for
the patient.
Citation: Filips A, Maurer MH, Montani M, Beldi G, Lachenmayer A. Inflammatory





Inflammatory myofibroblastic tumors (IMT) are rare diagnostic findings and little is
known about their etiology, pathogenesis and clinical behavior. First described in the
lungs,  this  rare  neoplasm can occur in various tissues and organs of  the human
body[1-4]. Whereas IMTs were originally considered as inflammatory pseudo tumors,
they are now recognized as true neoplasms in the histological typing of the soft tissue
tumors classification of the World Health Organization with intermediate biological
potential due to their ability to recur and to metastasize[1,4]. IMTs of the liver (IMTL)
are even more seldom and most published literature are case reports (Table 1) or
small case series (Table 2). Most patients present with either abdominal pain or fever,
in others the tumor is detected incidentally[5]. A systemic inflammatory process with
leukocytosis, elevated C-reactive protein (CRP) and other systemic inflammatory
markers  often  accompanies  the  clinical  presentation[3,5-11].  Although this  type  of
neoplasm can occur in individuals of all ages, it seems more common in children and
young adults[4,12]. The etiology of IMTL is unclear[4], but cytogenetic alterations suggest
a clonal  origin of  theses lesions[3,4].  Proof of  diagnosis  is  difficult  since no tumor
markers are available and radiological findings are often not specific[6,8,13]. Surgical
resection is usually considered as the treatment of choice for these rare findings.
IMTLs  mostly  present  as  solitary  lesions  with  typical  firm  surfaces.  Histopa-
thologically, they can have three basic patterns, which are often combined in one
tumor: (1) A myxoid/vascular; (2) Spindel cell; and (3) Hypocellular fibrous pattern[4].
The tumor is frequently infiltrated by eosinophils, lymphocytes and plasma cells[4].
Rearrangements of the anaplastic lymphoma kinase (ALK) gene locus are common in
IMTs  supporting  its  neoplastic  origin.  ALK  overexpression  and  its  positive
immunohistochemical staining is reported in 50%-60% of the cases[14].  Differential
diagnoses of IMTL include metastatic sarcomatoid carcinoma, spindel cell sarcoma or
melanoma,  gastrointestinal  stromal  tumor,  sarcoma,  solitary  fibrous  tumor  and
calcifying tumors besides the large group of inflammatory pseudotumors[6]. Although
these lesions generally show a benign behavior, there is the possibility of malignant
transformation and development of metastases[15,16]. Some small case series of IMTs
described the anatomic location, size and age as potential risk factors correlated with
recurrence[2,13,17]. In addition, ALK reactivity in the primary tumor was associated with
a non-metastatic course of the disease[6]. In the liver, a malignant transformation is
extremely rare and only very few cases with local recurrence or metastases have been
described[1,18]. Due to the scarcity of this disease, the role of a preoperative biopsy is
unclear, but because of the difficulty to obtain a proper histopathological diagnosis
and the risk of malignant transformation, surgical resection is usually recommended
whenever technically feasible[5,8,9,19,20].
We herein report the case of a 32-year-old woman who received an immediate
hepatic resection for a large IMTL causing intermittent fever 4 mo postpartum.
WJH https://www.wjgnet.com April 27, 2020 Volume 12 Issue 4




A 32-year old woman presented herself to her family doctor with intermittent fever,
unclear blood loss, malaise and pain in the right flank 4 mo postpartum.
History of present illness
The patient reported that the symptoms began 4 mo after she gave birth to her healthy
child. She complaint about fatigue and right upper quadrant abdominal pain. She had
recurrent episodes of fever up to 38.5 °C, but no jaundice or pruritus.
History of past illness
There was no significant history of past illnesses.
Personal and family history
Personal and family history was unremarkable. She gave birth to a healthy child 4 mo
before she was treated at our institution.
Physical examination upon admission
Vital  signs  were  within  the  normal  range,  body  temperature  was  38.5  °C.  On
examination, the patient had a right upper quadrant tenderness, without jaundice or
hepatosplenomegaly.
Laboratory examinations
Urine and most blood analyses were without any pathological findings including a
normal liver function and normal ferritin levels. While the white blood cell count was
normal,  CRP  was  elevated  to  181  mg/L.  The  liver  enzymes  (aspartate-
aminotransferase  31  U/L,  alkalic-aminotransferase  49  U/L)  and  cholestasis
parameters (alkalic-phosphatase 466 U/L, y-glutamyl transferase 424 U/L) showed
an increase while the serum bilirubin (6 μmol/L) stayed normal.
Imaging examinations
An ultrasound of the abdomen (Figure 1A) revealed a round, encapsulated liver
lesion in segment IVa/b of unclear dignity, a non-contrast computed tomography of
the abdomen ruled out urolithiasis, but confirmed the suspicious lesion of 8 cm in the
liver  as  an  incidental  finding.  The  computer  tomography  (CT)  and,  same  day
magnetic resonance imaging (MRI) of the upper abdomen (Figure 1B-F) showed an 8
cm × 8 cm tumor in segment IVa/b of the liver suspected to be a liver adenoma.
Additional serological tests for hepatitis, the tumor markers carbohydrate-antigen 19-
9 and alpha-fetoprotein,  and markers for echinococcosis were all  negative.  After
discussion of the case in our interdisciplinary liver tumor board on the next day, we
performed a positron emission tomography-computed tomography (PET-CT) which
showed the known lesion as a metabolically active tumor resembling an inflammatory
pseudotumor of the liver or a malignant tumor of unclear origin. No other lesions was
detected in any of the performed scans.
Further diagnostic work-up
The pathologist macroscopically (Figure 2) described the size of the resected specimen
as wedge-shaped and nodular, 9.5 cm × 7.0 cm × 7.5 cm. The capsule of the liver was
about unremarkable on one-half of the supplement. An area of 7.5 cm × 7.5 cm × 6.2
cm was sharply circumscribed, whitish/creamy and fibrous. No clearly definable
capsule.  The  remaining  liver  tissue  was  inconspicuous  and  showed  no  further
hereditary findings. The total weight of the tumor was 198 g. Immunohistochemistry
showed a clear expression of cytoplasmic ALK and a weak expression of smooth
muscle actin. Cytokeratin-PAN (CK Pan), Cytokeratin 18 (CK18), signal transducer
and activator of transcription protein 6 (STAT6),  Desmin, tyrosin-protein (C-kit),
discovered on gastrointestinal stromal tumors 1 (DOG1), ETS related gene (ERG),
family  of  calcium binding  protein  (S100)  and  SRY-related  HMG-box  10  Protein
(SOX10)  showed  no  expression.  The  intra-tumoral  immunoglobulin  G4  (IgG4)-
positive  plasma  cells  were  slightly  increased,  but  displayed  only  a  very  small
percentage of all plasma cells (Figure 3). The pathological diagnosis revealed an IMTL
with no fibrosis and no malignancy.
FINAL DIAGNOSIS
The final diagnosis of the presented case is an IMTL.
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Filips A et al. Inflammatory myofibroblastic tumor of the liver
Figure 1
Figure 1  Imaging features within the liver lesion in segment IV. A: The lesion was a first detected as an incidental finding in an unenhanced abdominal computed
tomography to rule out kidney stones (asterisk); B: Conformed with an ultrasound examination (asterisk); C: In a following magnetic resonance imaging the lesion
showed a homogeneous high signal in T2-weighted imaging (asterisk); D: After the application of intravenous hepatocyte specific contrast medium (gadoxetic acid,
Primovist®/Eovist®, Bayer Healthcare Pharmaceuticals, Leverkusen, Germany) there was an early enhancement at the rim in the arterial phase (arrow); E: Followed
by a strong enhancement in the venous phase (arrow); F: In the hepatobiliary phase after 20 min, the lesion appeared with a low intracellular uptake of the contrast
medium compared with the adjacent liver tissue; G: In the diffusion-weighted imaging there was no clear diffusion restriction detection within the lesion (apparent
diffusion coefficient); H: In an additional positron emission tomography-computed tomography examination the lesion showed an intensively increased tracer uptake; I:
A follow-up magnetic resonance imaging examination after 3 mo confirmed a complete surgical resection (with multiple artifacts at the resection margin due to multiple
clips) and ruled out new hepatic lesions.
TREATMENT
Due to the unclear situation with fever and the suspicion of  a large adenoma or
malignant  tumor  of  the  liver,  an  immediate  surgical  resection  was  performed.
Intraoperatively, the solitary central lesion could be confirmed by intraoperative
ultrasound, which also excluded additional liver lesions. An open resection of the
liver segment IVa/b was performed achieving a negative resection margin. While no
intra-operative complications occurred, the patient developed a bilioma, which had to
be drained interventionally 7 d after the surgery accompanied by an endoscopic
retrograde cholangiopancreatography with stent insertion.
OUTCOME AND FOLLOW-UP
The case was discussed postoperatively in our interdisciplinary liver tumor board to
determine the postoperative management. While no adjuvant therapy was indicated,
it was recommended to follow the patient clinically by MRI imaging every 3 mo after
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Figure 2
Figure 2  Postoperative macroscopic pathology of the inflammatory myofibroblastic tumors.
the surgery for the duration of at least one year.
The patient returned to work and MRIs of the liver 3, 6 and 12 mo after resection
showed no local recurrence and no novel liver lesions.
DISCUSSION
We herein present and discuss the case of a 32-year-old woman who presented with a
suspicious and symptomatic liver mass consequently diagnosed as IMTL.
IMTs of the liver are extremely rare findings that can sometimes mimic malignant
lesions[6]. In terms of demographics, the tumor seems to be more common in men than
in women (M/F: 1.5/1) with a mean age at diagnosis of 37 years[7].  IMTL usually
occur in the right liver lobe, in close proximity to the gallbladder or central biliary
system[7,8].  Typical clinical findings reported in the literature are fever, abdominal
pain, lack of strength and weight loss[7], which all occurred in our case (intermittent
fever, unclear blood loss, malaise and pain in the right flank) and led to the ultimate
diagnosis. In addition to the fever, laboratory findings often suggest inflammation
due to leukocytosis, neutrophilia and elevated CRP[5,6,8,10]. More rarely, anemia and
sometimes also elevated liver enzymes are reported[6]. According to the clinical signs
of infection, some individual cases were reported to be correlated with different active
(virus) infections[5,18,19,21,22].  In our patient,  the antibody to Epstein-Barr virus was
positive in the serological findings without any signs of an active Epstein-Barr virus
infection. A clear association between IMT and infectious organisms seems to be
doubtful  since  in  most  reported  series,  including  our  own  case,  no  acid-fast
organisms, fungi, parasites or bacteria could be identified in the tumor[10,19].
Radiological features of IMTLs are nonspecific and a definite radiological diagnosis
seems to be impossible. Due to the small cases (Tables 1 and 2) we could see, that the
tumor in ultrasonography mostly was hypoechogenic. An IMT may be suspected if a
defined soft tissue mass and a heterogeneous enhancement with invasive or non-
invasive growth are present on adjacent structures in CT or MRI[6,8,23]. Not all patients
underwent a MRI for diagnostic treatment, only in eight cases[17,24-29]. Al-Hussaini et
al[24] and Kayashima et al[30] described a contrast-enhancing, hyper-intense well defined
lesion  without  going  into  details.  In  four  cases  the  lesion  in  T1W  was  mostly
hypointense and T2W hyperintense[17,25,26,28]. Despite its rarity, lack of diagnostic signs
and symptoms, IMTL should not be ruled out as a differential  diagnosis in liver
lesions  like  focal  nodular  hyperplasia,  hepatocellular  adenoma,  carcinoma  and
ecchinococcosis  especially  in  young  patients  with  normal  tumor  markers[7].  In
addition IMTL can sometimes mimic a liver abscess[22]. Although many synonyms
have been used for this lesion, including plasma cell granuloma, postinflammatory
tumor, xanthomatous pseudotumor, inflammatory pseudotumor, and inflammatory
fibrosarcoma[31],  the  new  classification  clearly  suggests  the  term  inflammatory
myofibroblastic tumor of its suitable origin or organ, in our case an IMTL[4].
Due to the small number of cases worldwide (Tables 1 and 2), no clear diagnostic
tests or radiographic features exist that help to make a definite diagnosis without a
histopathological  examination  of  the  tissue[10].  We  performed  a  comprehensive
literature search and studied the cases published during the last 10 years[5,7,17,24-30,32-47].
There were more men affected than women. The most common localization of the
tumor was on the right lobe of the liver. All patients in the described cases had at least
an  ultrasonography  and/or  a  CT.  In  some  cases,  the  diagnostic  work-up  was
completed with MRI, MRCP or PET-CT. Due to the different radiological findings the
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Figure 3
Figure 3  Postoperative microscopic pathology of the inflammatory myofibroblastic tumors. A: Well demarcated firm vascularized tumor mass with spotty
inflammatory infiltrate; B: Bland proliferation of spindle cells in broad fascicles at higher magnification. Scattered lymphocytes and plasma cell; C: Intense positivity of
the spindel cells for anaplastic lymphoma kinase.
tentative diagnose showed a large variation from liver abscess, inflammatory process
and also malignancy.
In the gross  examination of  the  resected specimen,  most  findings showed the
similar  finding  of  a  well-demarcated,  unencapsulated,  yellow-whitish  mass.
Histologically  infiltrations  of  chronic  inflammatory-cells  like  lymphocytes,
neutrophils,  eosinophils,  and  macrophages  were  often  described.  Whenever
immunohistochemical analyses were performed, ALK expression showed a similar
distribution. The performed treatment of the different cases varied according to the
initially suspected diagnose. In summary, more patients were treated conservatively,
although there is no clear indication for such a treatment. Surgical resections were
performed according to the size and location of the suspected tumor and varied from
small atypical resections to major hepatectomies. In most of the cases the definite
histology report of the resected specimen then showed the diagnosis of an IMTL-
Unfortunately, follow-up was not described in all published cases. Except for one
reported recurrence after 2.5 years, most patients stayed tumor-free during a follow-
up ranging from X-Y months[48].
Surgical resection is usually recommended so that a proper pathological work-up
can be performed and malignancy can be ruled out. Nevertheless, several different
treatment strategies have been published including conservative approaches with
steroids, high-dose steroids, radiation and chemotherapy[6-8,11]. Interestingly, one case
with  a  spontaneous  regression has  also  been reported[17].  A typical  pathological
finding is that the IMTL’s are unencapsulated. They are usually solid or gelatinous on
the intersection and have a white color. Hemorrhage, calcification or necrosis are
rarely described[6,12], similar to the pathological findings in our case. As described by
Elpek et al[6],  chromosomal translocations leading to the activation of ALK can be
detected  in  IMTLs.  Although  immunohistochemistry  for  ALK  expression  in
immunohistochemistry can reliably predict the presence of ALK gene rearrangement,
its  prognostic  relevance is  still  unclear[14,49].  IMTLs differ  from IgG4-related liver
disease in terms of ALK expression, low IgG4 positive cell infiltration, and lack of
obstructive phlebitis[6].
The natural course of IMTL without curative surgical therapy is unclear. To date,
only  a  few cases  have been described in  which patients  had local  recurrence  or
metastases  after  liver  resections[15,16,48].  Due  to  the  small  numbers  published
worldwide,  no recommendations for  the  follow-up are  available  and patients  is
treated according to the decisions made in the local interdisciplinary tumor boards. In
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our case, the finding of the pseudotumor was 4 mo postpartum. Due to the rather
large size of the lesion it was considered an advanced lesion. The pregnancy may
have masked general symptoms such as nausea, vomiting, and abdominal pain. So
far, only one case of newly diagnosed IMTL has been reported during pregnancy[18].
CONCLUSION
In summary of  the literature and with the experience from our own recent  case,
complete surgical resection of a suspected IMTL should be the preferred treatment of
choice in order to rule out malignancy, avoid long-term medical treatment and to be
able to recommend an appropriate follow-up for the patient.
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